Article info
Original research
Uninformed refusals: objections to enrolment in clinical trials conducted under an Exception from Informed Consent for emergency research
- Correspondence to Dr Neal W Dickert, Division of Cardiology, ECCRI, Emory University School of Medicine, Atlanta, GA 30329, USA; njr{at}emory.edu
Citation
Uninformed refusals: objections to enrolment in clinical trials conducted under an Exception from Informed Consent for emergency research
Publication history
- Received December 29, 2017
- Revised August 22, 2018
- Accepted August 23, 2018
- First published September 15, 2018.
Online issue publication
December 13, 2018
Article Versions
- Previous version (13 December 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Informed consent for functional MRI research on comatose patients following severe brain injury: balancing the social benefits of research against patient autonomy
- Assent in paediatric research: theoretical and practical considerations
- Can informed consent to research be adapted to risk?
- Association of out-of-hospital advanced airway management with outcomes after traumatic brain injury and hemorrhagic shock in the ROC hypertonic saline trial
- Is best interests a relevant decision making standard for enrolling non-capacitated subjects into clinical research?
- Military medical research in Britain and the USA: the challenge of informed consent
- Emergency care research ethics in low-income and middle-income countries
- Community of trauma care partnering with stakeholders to improve injury outcomes: focus group analysis
- Limits to research risks
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent